ArticleFrontiers in immunology2025

DDR1 as a key prognostic biomarker in non-small cell lung cancer: identification, validation, and potential therapeutic implications.

RenCai Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.